Cholestyramine and Pregabalin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Cholestyramine (cholestyramine) and Pregabalin (pregabalin). Common drug interactions include dizziness among females and dyspnoea among males.
The phase IV clinical study analyzes what interactions people have when they take Cholestyramine and Pregabalin. It is created by eHealthMe based on reports of 159 people who take the same drugs from the FDA, and is updated regularly.
What is Cholestyramine?
Cholestyramine has active ingredients of cholestyramine. It is often used in diarrhea. eHealthMe is studying from 9,893 Cholestyramine users. Check the latest studies of Cholestyramine.
What is Pregabalin?
Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,069 Pregabalin users. Check the latest studies of Pregabalin.
159 people who take Cholestyramine and Pregabalin together, and have interactions are studied.
What are the common drug interactions of Cholestyramine and Pregabalin, by gender? *
What are the common drug interactions of Cholestyramine and Pregabalin, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Cholestyramine and Pregabalin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Cholestyramine (9,893 reports)
- Pregabalin (74,069 reports)
Browse all drug interactions of Cholestyramine and Pregabalin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cholestyramine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Pregabalin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cholestyramine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pregabalin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .
How the study uses the data?
The study uses data from the FDA. It is based on cholestyramine and pregabalin (the active ingredients of Cholestyramine and Pregabalin, respectively), and Cholestyramine and Pregabalin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Elavil cause Musculoskeletal Pain? - 17 seconds ago
- Could Zetia cause Infusion Site Haemorrhage? - 20 seconds ago
- Could Prilosec cause Blood Immunoglobulin A Decreased? - 23 seconds ago
- Could Acetaminophen And Hydrocodone Bitartrate cause Swallowing Difficulty? - 25 seconds ago
- Postoperative Analgesia and Depressed Level Of Consciousness - 28 seconds ago
- Drug interactions of Chlorpheniramine Maleate and Dalfampridine - 40 seconds ago
- Could Humalog cause Pulmonary Oedema Aggravated? - 44 seconds ago
- Could Gilenya cause Rebound Effect? - 48 seconds ago
- Could Sildenafil Citrate cause Hyperhidrosis? - a minute ago
- Could Biaxin cause Appetite - Increased? - a minute ago